Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.

Item
http://www.wikidata.org/entity/Q33388513
China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)Lung cancer in never smokersEGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published dataBrain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activationPhase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience.Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma.A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer.The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma.The role of systemic and targeted therapies in brain metastases.Erlotinib for the treatment of brain metastases in non-small cell lung cancer.Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease.
P2860

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.

Item
http://www.wikidata.org/entity/Q33388513
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@ast
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@en
type
label
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@ast
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@en
prefLabel
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@ast
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Clinical outcomes in extracran ...... (NSCLC) with brain metastasis.
@en
P2093
P304
P31
P356
10.1016/J.LUNGCAN.2010.01.018
P433
P478
P577
P698